The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: Mechanisms and implications

Biochemistry and Cell Biology

Volumn 75, Issue 4, 1997, Pages 315-325

  Alaoui Jamali, Moulay A ^a,c   Paterson, Jesse ^a   Al Moustafa, Ala Eddin ^b   Yen, Lily ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Apoptosis; Cell cycle checkpoints; DNA repair; Drug resistance; erbB receptors

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ANIMAL; DRUG RESISTANCE; HUMAN; PHYSIOLOGY; REVIEW;

ANIMALS; DRUG RESISTANCE, NEOPLASM; HUMANS; RECEPTOR, ERBB-2;

EID: 0031298124     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o97-060     Document Type: Article

References (6)

1. Alimandi, M., Romano, A., Curia, M.C., Muraro, R., Fedi, P., Aaronson, S.A., Di Fiore, P.P., and Kraus, M.H. 1995. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene, 10: 1813-1821.
2. Al-Kasspooles, M., Moore, J.H., Orringer, M.B., and Beer, D.G. 1993. Amplification and overexpression of the EGFR and erbB-2 genes in human esophageal adenocarcinomas. Int. J. Cancer, 54: 213-219.
3. Arai, Y., Yoshiki, T., and Yoshida, O. 1997. C-ErbB-2 oncoprotein: a potential biomarker of advanced prostate cancer. Prostate, 30: 195-201.
4. Ariza, R.R., Keyse, S.M., Moggs, J.G., and Wood, R.D. 1996. Reversible protein phosphorylation modulates nucleotide excision repair of damaged DNA by human cell extracts. Nucleic Acids Res. 24: 433-440.
5. c-erbB-2 signaling enhances cisplatin-induced cytotoixicity in human breast carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair. Cancer Res. 54: 3758-3765.
6. Bacus, S.S., and Yarden, Y. 1996. An immunological approach reveals biological differences between the two NDF/heregulin receptors, erbB-3 and erbB-4. J. Biol. Chem. 271: 7620-7629.